The chronic mild stress (CMS) model of depression: History, evaluation and usage.

Willner P. · 2017

Read The chronic mild stress (CMS) model of depression: History, evaluation and usage. by Willner P. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5314424.txt.

Introduction

Paul Willner reviewed a rat and mouse model of depression in Neurobiology of Stress in 2017. In the model, called chronic mild stress, animals face a stream of small, varied stressors for weeks. They then lose interest in sweet rewards, a sign meant to mirror loss of pleasure in human depression. The model was thirty years old at the time of the review.

Willner traces the model's history and weighs how well it holds up. A survey of users showed that its many names hide one shared method. More than a thousand studies had used it, with use still rising. The review sums up what the model shows about brain changes in depression, with stress on the hippocampus and front brain areas. It also covers how mood drugs act in the model, a rich source for drug hunting.

Catalog record

CREATORWillner P.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE124 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5314424

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The chronic mild stress (CMS) model of depression: History, evaluation and usage By Paul Willner Published in: Neurobiology of Stress DOI: 10.1016/j.ynstr.2016.08.002 ABSTRACT Abstract Now 30 years old, the chronic mild stress (CMS) model of depression has been used in >1300 published studies, with a year-on-year increase rising to >200 papers in 2015. Data from a survey of users show that while a variety of names are in use (chronic mild/unpredictable/varied stress), these describe essentially the same procedure. This paper provides an update on the validity and reliability of the CMS model, and reviews recent data on the neurobiological basis of CMS effects and the mechanisms of antidepressant action: the volume of this research may be unique in providing a comprehensive account of antidepressant action within a single model. Also discussed is the use of CMS in drug discovery, with particular reference to hippocampal and extra-hippocampal targets. The high translational potential of the CMS model means that the neurobiological mechanisms described may be of particular relevance to human depression and mechanisms of clinical antidepressant action. Keywords: Depression, Chronic mild stress, Validity, Reliability, Neurobiology of stress, Antidepressant, Hippocampus, Prefrontal cortex INTRODUCTION Animal models of psychiatric states are procedures applied to laboratory animals which engender behavioural changes that are intended to be homologous to aspects of psychiatric disorders, and can therefore be used as experimental tools to further the understanding of human psychopathology (Willner, 2009). The chronic mild stress (CMS) model of depression (Willner et al., 1992, Willner, 1997) is often considered as a prototypical example. In this model, rats or mice are exposed chronically to a constant bombardment of unpredictable micro-stressors, resulting in the development of a plethora of behavioural changes, including decreased response to rewards, a behavioural correlate of the clinical core symptom of depression, anhedonia. In the canonical version of the model, reward sensitivity is tracked by periodic tests in which the animal is given access to a highly preferred sweet solution, or to a choice between a sweet solution and plain water. Consumption of, or preference for, the sweet reward decreases over weeks of exposure but can be restored to normal levels by chronic treatment with antidepressant drugs. This paper presents a historical overview of the CMS model, considers some areas of controversy, and reviews recent research in three major areas of application: neurobiological processes mediating the effects of chronic stress, cellular and systemic mechanisms of antidepressant action, and antidepressant drug discovery. The focus of the review is on the specific contributions of CMS research, rather than an integration of CMS studies with the wider literature. The aim, in taking this approach, was to explore how comprehensive a story this single model provides. ORIGINS The origin of the CMS model was in series of studies by Katz and colleagues, published in the early 1980s, in which rats were exposed sequentially to a variety of severe stressors. Most of these studies assessed the effects of stress using changes in open field behaviour, which were reported to be reversed specifically by chronic treatment with antidepressant drugs, but not by non-antidepressants (e.g. Katz and Hersch, 1981, Katz et al., 1981a, Katz et al., 1981b, Katz and Baldrighi, 1982). However, in one study, it was observed that animals exposed to the chronic stress regime failed to increase their fluid consumption when saccharin or sucrose were added to their drinking water, and it was postulated that this might reflect a decrease in the hedonic impact of the sweetener (Katz, 1982). This hypothesis was supported by the demonstration by Anisman and colleagues that uncontrollable footshock can lead to impairments of behaviour maintained by brain stimulation reward (Zacharko et al., 1983, Zacharko et al., 1984). The importance of anhedonia (the decreased ability to experience pleasure) as a core symptom of depression, both then and now (American Psychiatric Association, 2013), stimulated research to develop and validate a model of stress-induced anhedonia as a tool, initially, to study the mechanisms of antidepressant action. In addition to making hedonic measures the primary focus of the model, a second change to the procedure described by Katz and colleagues was that the severity of the stressors employed was greatly reduced. This change was made for ethical reasons, and in the context of the Animals (Scientific Procedures) Act (1986) that had very recently tightened the framework for animal research in the UK, placing an emphasis on minimizing stress wherever possible. Consequently, the CMS regime as initially developed did not include any of the severely stressful elements used by Katz and colleagues, such as intense footshock, cold water immersion, or prolonged (48 h) food and water deprivation. The birth of the CMS procedure was in a lab meeting in 1986 where those present brainstormed the problems that might arise if animals were curated by a thoroughly incompetent technician: water bottles might leak into the bedding; it might not be noticed that food and water supplies needed replenishment; the light-dark cycle in the animal house, and the lights themselves, might malfunction; housing conditions might change unpredictably; the environment might be noisy; and so on. All of the ideas generated were then implemented in a combination that was unremitting (no stress-free periods) and continuous over many weeks (the chronic element of CMS). For licensing purposes under the 1986 Act, all of the individual micro-stressors were considered to be ‘mild’ but the overall procedure was given a ‘moderately stressful’ banding. The first publication using the CMS procedure reported that rats exposed chronically (5–9 weeks) to CMS, and tested weekly, showed a reduced consumption of, and preference for, weak solutions of saccharin or sucrose, which developed over the course of several weeks exposure, and that the decreased sucrose preference was restored by 2–4 weeks of treatment with a tricyclic antidepressant (Willner et al., 1987). Over the next few years, this observation was extended to other typical and atypical antidepressants (e.g. Muscat et al., 1992, Cheeta et al., 1994, Papp et al., 1996), and the behavioural effects of CMS were more fully characterized (e.g. Muscat and Willner, 1992, D'Aquila et al., 1994, Cheeta et al., 1997), in particular by the observation that behavioural changes compatible with anhedonia were seen not only in consumption tests but also using place preference conditioning methods (e.g. Papp et al., 1991, Papp et al., 1992), and a comparable CMS procedure was implemented in mice (Monleon et al., 1994). This period also saw the first use of the CMS model to study brain mechanisms underlying antidepressant action, with a particular focus at that time on the mesolimbic dopamine system, which had been somewhat overlooked in earlier depression research (e.g. Stamford et al., 1991, Papp et al., 1994, Dziedzicka-Wasylewska et al., 1997), suggesting a novel direction for antidepressant drug development (e.g. Muscat et al., 1992, Willner et al., 1994). Other labs began to take up the CMS procedure, with a particularly important contribution by Moreau et al., 1992, Moreau et al., 1993 who reported that CMS-induced anhedonia, and its reversal by chronic antidepressant treatment, could also be demonstrated as a change in the threshold for intracranial self-stimulation of the ventral tegmental area. A 1997 review of the first ten years of CMS research identified 12 additional labs that were working with the CMS as

Read the complete text